Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

440 results

What's next in DES technology? Innovative DES platforms combining DES with DCB

19 May 2022 – From EUROPCR 2022

Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...

What's next in DES technology? Innovative DES platforms combining DES with DCB

Nothing to fear - a guide to combine DCB and DES in hybrid PCI

19 May 2022 – From EuroPCR 2022

DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.

Nothing to fear - a guide to combine DCB and DES in hybrid PCI

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

18 May 2022 – From EuroPCR 2022

What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve

18 May 2022 – From EuroPCR 2022

The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...

Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent and VitaFlow valve

Pressure microcatheter guided PCI: to optimise stent implantation and to safely assess the functional result

18 May 2022 – From EuroPCR 2022

Through the case study of a 71-year-old female patient with hypertension, dyslipidemia, previous TIA, and stress-induced chest pain, among other things, this EuroPCR 2022 session will allow you to understand the major role of longitudinal functional evaluation of CAD, learn tips and tricks in using pressure microcatheter in PCI...

Pressure microcatheter guided PCI: to optimise stent implantation and to safely assess the functional result

The current role of paclitaxel DCB in PCI

18 May 2022 – From EuroPCR 2022

Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...

The current role of paclitaxel DCB in PCI

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!

18 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!

Stent failure: how to treat, how to prevent

18 May 2022 – From EuroPCR 2022

With 2 expert interviews, a stent failure case example, and a recorded best practice case to prevent stent failure in this EuroPCR 2022 session, understand why unraveling the mechanism of stent failure is essential for optimal treatment, receive tips and tricks to effectively treat stent failure,...

Stent failure: how to treat, how to prevent

Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release

18 May 2022 – From EuroPCR 2022

Thanks to this EuroPCR 2022 session, discuss how sustained limus release technology can broaden DEB indications, learn about the decision-making process on the use of DEB adjacent to DES in complex PCI, and review DEB specific implantation techniques to achieve optimal outcomes for the patient.

Redefining indications for drug-eluting balloons in complex PCI - The role of sustained limus release